NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries
NEW YORK, June 6, 2023 /PRNewswire/ -- NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries.
- NEW YORK, June 6, 2023 /PRNewswire/ -- NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries.
- "This collaboration will give our researchers new options to bring promising biomedical innovations into treatments and cures that will address some of the world's most pressing health issues.
- Amethyst Innovations, LLC, a private company wholly owned by affiliates of Deerfield Management, will support NYU Langone research projects in various stages of drug exploration and development.
- Under the terms of the agreement, Amethyst Innovations, LLC would receive an option to license Amethyst Innovations-funded intellectual property developed at NYU Langone.